Kaixin Holdings: Recent Developments and Market Performance

Kaixin Holdings, an investment company operating in the Consumer Discretionary sector, is headquartered in Hong Kong. The company is listed on the Nasdaq and trades in USD. As of May 19, 2025, Kaixin Holdings closed at $1.01 USD. The company’s market capitalization stands at $10,150,000 USD.

In recent developments, Kaixin Pharmaceuticals, a subsidiary of Kaixin Holdings, experienced a significant event on May 12, 2025. CASI Pharmaceuticals sold equity and rights to Kaixin Pharmaceuticals, marking a notable transaction in the company’s recent history. Despite this development, Kaixin Pharmaceuticals has not issued any further news updates.

From a market performance perspective, Kaixin Holdings has experienced considerable volatility over the past year. The company’s 52-week high was $29.544 USD on October 3, 2024, while the 52-week low was $0.63581 USD on April 7, 2025. The last closing price before May 19 was $0.95 USD. Financial ratios indicate a price-to-earnings ratio of -0.042488 and a book ratio of 0.46388.

These figures reflect the dynamic nature of Kaixin Holdings’ market presence and highlight the recent strategic moves within its pharmaceutical division.